AbCellera Biologics Inc. (NASDAQ:ABCL) Q4 2025 Earnings Call Transcript

AbCellera Biologics Inc. (NASDAQ:ABCL) Q4 2025 Earnings Call Transcript February 24, 2026

AbCellera Biologics Inc. beats earnings expectations. Reported EPS is $-0.02995, expectations were $-0.18.

Operator: Good afternoon, and welcome to AbCellera’s Full Year 2025 Business Update Conference Call. My name is Chelsea, and I will facilitate the audio portion of today’s interactive broadcast. [Operator Instructions] At this time, I would like to turn the call over to Tryn Stimart, AbCellera’s...